IOVA icon

Iovance Biotherapeutics
IOVA

Overview Fund Activity

272 hedge funds and large institutions have $3.22B invested in Iovance Biotherapeutics in 2024 Q1 according to their latest regulatory filings, with 70 funds opening new positions, 90 increasing their positions, 82 reducing their positions, and 33 closing their positions.

Holders
272
Holders Change
+37
Holders Change %
+15.74%
% of All Funds
3.94%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.12%
New
70
Increased
90
Reduced
82
Closed
33
Calls
$93.8M
Puts
$31.4M
Net Calls
+$62.4M
Net Calls Change
+$27.6M

Top Buyers

1
PA
1
Perceptive Advisors
New York
$286M
2
ACA
2
Avoro Capital Advisors
New York
$173M
3
MFM
3
MHR Fund Management
New York
$356M
4
SPPAM
4
Summit Partners Public Asset Management
Massachusetts
$44M
5
SCM
5
Soleus Capital Management
Connecticut
$51.9M

Top Sellers

1
State Street
1
State Street
Massachusetts
$154M
2
Morgan Stanley
2
Morgan Stanley
New York
$39.9M
3
Balyasny Asset Management
3
Balyasny Asset Management
Illinois
$17.8M
4
O
4
OrbiMed
New York
$0
5
Pictet Asset Management
5
Pictet Asset Management
Switzerland
$47.5M
Name Market Value Shares Shares
Change 		Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$369M 24,915,300 +2,102,480 +9%
MFM
2
MHR Fund Management
New York
$356M 23,997,103 +4,000,000 +20%
BlackRock
3
BlackRock
New York
$295M 19,929,702 +857,946 +4%
PA
4
Perceptive Advisors
New York
$286M 19,272,991 +7,293,576 +61%
ACA
5
Avoro Capital Advisors
New York
$173M 11,700,000 +5,000,000 +75%
State Street
6
State Street
Massachusetts
$154M 10,402,719 -6,021,669 -37%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$81.6M 5,506,617 +469,519 +9%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$78.1M 5,267,864 +1,991,262 +61%
Artisan Partners
9
Artisan Partners
Wisconsin
$76.1M 5,138,222 +310,552 +6%
JPMorgan Chase & Co
10
JPMorgan Chase & Co
New York
$65M 4,385,694 +1,546,027 +54%
Goldman Sachs
11
Goldman Sachs
New York
$56.1M 3,782,563 +101,003 +3%
SCM
12
Soleus Capital Management
Connecticut
$51.9M 3,505,000 +2,950,000 +532%
Voloridge Investment Management
13
Voloridge Investment Management
Florida
$51.8M 3,494,184 +2,511,104 +255%
Pictet Asset Management
14
Pictet Asset Management
Switzerland
$47.5M 3,250,554 -2,012,755 -38%
SPPAM
15
Summit Partners Public Asset Management
Massachusetts
$44M 2,965,987 +2,965,987 New
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$42.6M 2,871,498 -645,489 -18%
Morgan Stanley
17
Morgan Stanley
New York
$39.9M 2,691,021 -4,740,069 -64%
HRCM
18
Hood River Capital Management
Florida
$38.9M 2,624,238 +622,728 +31%
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$34.9M 2,352,166 +2,137,032 +993%
Northern Trust
20
Northern Trust
Illinois
$33M 2,227,344 +44,467 +2%
MB
21
MPM BioImpact
Massachusetts
$32.6M 2,200,000 -1,089,470 -33%
PAI
22
Palo Alto Investors
California
$31.3M 2,112,811 +6,019 +0.3%
CS
23
Credit Suisse
Switzerland
$29.8M 2,008,046 -806,270 -29%
Principal Financial Group
24
Principal Financial Group
Iowa
$29.7M 2,005,905 -630,422 -24%
Charles Schwab
25
Charles Schwab
California
$28.4M 1,913,100 +166,077 +10%
1
2 3 4 5